Published in Medical Letter on the CDC and FDA, September 13th, 2009
"To further understand the effect of lcrG deletion on Y pestis T3SS regulation, transcriptional profiles from the Delta lcrG mutant and wild-type Y pestis strains were compared. The results showed that although the Delta lcrG mutant was markedly attenuated (600-fold increase of LD50 in s.c. challenged BALB/c mice),...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.